BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

124 related articles for article (PubMed ID: 10960837)

  • 1. Comparison of the activation status of tumor infiltrating and peripheral lymphocytes of patients with adenocarcinomas and benign hyperplasia of the prostate.
    Elsässer-Beile U; Przytulski B; Gierschner D; Grussenmeyer T; Katzenwadel A; Leiber C; Deckart A; Wetterauer U
    Prostate; 2000 Sep; 45(1):1-7. PubMed ID: 10960837
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Different expression of Fas and Fas ligand in tumor infiltrating and peripheral lymphocytes of patients with renal cell carcinomas.
    Elsässer-Beile U; Gierschner D; Welchner T; Wetterauer U
    Anticancer Res; 2003; 23(1A):433-7. PubMed ID: 12680244
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Enhanced expression of IFN-gamma mRNA in CD4(+)or CD8(+)tumour-infiltrating lymphocytes compared to peripheral lymphocytes in patients with renal cell cancer.
    Elsässer-Beile U; Rindsfüser M; Grussenmeyer T; Schultze-Seemann W; Wetterauer U
    Br J Cancer; 2000 Sep; 83(5):637-41. PubMed ID: 10944605
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Semiquantitative analysis of Th1 and Th2 cytokine expression in CD3+, CD4+, and CD8+ renal-cell-carcinoma-infiltrating lymphocytes.
    Elsässer-Beile U; Grussenmeyer T; Gierschner D; Schmoll B; Schultze-Seemann W; Wetterauer U; Schulte Mönting J
    Cancer Immunol Immunother; 1999 Jul; 48(4):204-8. PubMed ID: 10431690
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Analysis of the immune reactivity of infiltrating and peripheral lymphocytes from patients with renal cell carcinoma by measuring cytokine secretion.
    Elsässer-Beile U; Wetterauer U; Schultze-Seemann W; Gallati H; Mönting JS; von Kleist S
    Cancer Immunol Immunother; 1996 Feb; 42(2):93-8. PubMed ID: 8620526
    [TBL] [Abstract][Full Text] [Related]  

  • 6. High expression of adhesion molecules/activation markers with little interleukin-2, interferon gamma, and tumor necrosis factor beta gene activation in fresh tumor-infiltrating lymphocytes from lung adenocarcinoma.
    Roussel E; Gingras MC; Grimm EA; Roth JA
    Cancer Immunol Immunother; 1995 Jul; 41(1):1-9. PubMed ID: 7641214
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Different basal expression of type T1 and T2 cytokines in peripheral lymphocytes of patients with adenocarcinomas and benign hyperplasia of the prostate.
    Elsässer-Beile U; Gierschner D; Jantscheff P; Schultze-Seemann W; Katzenwadel A; Wetterauer U
    Anticancer Res; 2003; 23(5A):4027-31. PubMed ID: 14666714
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Cytokine expression pattern in benign prostatic hyperplasia infiltrating T cells and impact of lymphocytic infiltration on cytokine mRNA profile in prostatic tissue.
    Steiner GE; Stix U; Handisurya A; Willheim M; Haitel A; Reithmayr F; Paikl D; Ecker RC; Hrachowitz K; Kramer G; Lee C; Marberger M
    Lab Invest; 2003 Aug; 83(8):1131-46. PubMed ID: 12920242
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Tumor-infiltrating lymphocytes contain higher numbers of type 1 cytokine expressors and DR+ T cells compared with lymphocytes from tumor draining lymph nodes and peripheral blood in patients with cancer of the uterine cervix.
    Santin AD; Ravaggi A; Bellone S; Pecorelli S; Cannon M; Parham GP; Hermonat PL
    Gynecol Oncol; 2001 Jun; 81(3):424-32. PubMed ID: 11371133
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Differential effects of interleukin-2 and CD3 triggering on cytokine gene transcription and secretion in cultured tumor infiltrating lymphocytes.
    Filgueira L; Zuber M; Juretic A; Lüscher U; Caetano V; Harder F; Garotta G; Heberer M; Spagnoli GC
    Cell Immunol; 1993 Aug; 150(1):205-18. PubMed ID: 8343966
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Phenotype, cytokine production and cytolytic capacity of fresh (uncultured) tumour-infiltrating T lymphocytes in human renal cell carcinoma.
    Van den Hove LE; Van Gool SW; Van Poppel H; Baert L; Coorevits L; Van Damme B; Ceuppens JL
    Clin Exp Immunol; 1997 Sep; 109(3):501-9. PubMed ID: 9328129
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Characterisation of cytokine mRNA expression in tumour-infiltrating mononuclear cells and tumour cells freshly isolated from human colorectal carcinomas.
    Csiszár A; Szentes T; Haraszti B; Zou W; Emilie D; Petrányi G; Pócsik E
    Eur Cytokine Netw; 2001 Mar; 12(1):87-96. PubMed ID: 11282551
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The pattern of cytokine gene expression in freshly excised human metastatic melanoma suggests a state of reversible anergy of tumor-infiltrating lymphocytes.
    Lüscher U; Filgueira L; Juretic A; Zuber M; Lüscher NJ; Heberer M; Spagnoli GC
    Int J Cancer; 1994 May; 57(4):612-9. PubMed ID: 8181865
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Selective cytokine gene expression in renal cell carcinoma tumor cells and tumor-infiltrating lymphocytes.
    Wang Q; Redovan C; Tubbs R; Olencki T; Klein E; Kudoh S; Finke J; Bukowski RM
    Int J Cancer; 1995 Jun; 61(6):780-5. PubMed ID: 7790111
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Expression of mRNA for cytokines in tumor-infiltrating mononuclear cells in ovarian adenocarcinoma and invasive breast cancer.
    Vitolo D; Zerbe T; Kanbour A; Dahl C; Herberman RB; Whiteside TL
    Int J Cancer; 1992 Jun; 51(4):573-80. PubMed ID: 1601521
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Cytokine biosynthesis by tumor-infiltrating T lymphocytes from human non-small-cell lung carcinoma.
    Ortegel JW; Staren ED; Faber LP; Warren WH; Braun DP
    Cancer Immunol Immunother; 2000 Feb; 48(11):627-34. PubMed ID: 10663610
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Tumor specific cytolysis by tumor infiltrating lymphocytes in breast cancer.
    Baxevanis CN; Dedoussis GV; Papadopoulos NG; Missitzis I; Stathopoulos GP; Papamichail M
    Cancer; 1994 Aug; 74(4):1275-82. PubMed ID: 7914469
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Progression of benign prostatic hyperplasia is associated with pro-inflammatory mediators and chronic activation of prostate-infiltrating lymphocytes.
    Norström MM; Rådestad E; Sundberg B; Mattsson J; Henningsohn L; Levitsky V; Uhlin M
    Oncotarget; 2016 Apr; 7(17):23581-93. PubMed ID: 26993768
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Sensitization of immunoresistant prostate carcinoma cell lines to Fas/Fas ligand-mediated killing by cytotoxic lymphocytes: independence of de novo protein synthesis.
    Frost PJ; Belldegrun A; Bonavida B
    Prostate; 1999 Sep; 41(1):20-30. PubMed ID: 10440872
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Phenotypic and functional analysis of tumor-infiltrating lymphocytes compared with tumor-associated lymphocytes from ascitic fluid and peripheral blood lymphocytes in patients with advanced ovarian cancer.
    Santin AD; Hermonat PL; Ravaggi A; Bellone S; Roman JJ; Smith CV; Pecorelli S; Radominska-Pandya A; Cannon MJ; Parham GP
    Gynecol Obstet Invest; 2001; 51(4):254-61. PubMed ID: 11408737
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.